Sanofi, a pharmaceutical company, is planning to cut 99 jobs at its sites in Ghent and Diegem as part of a global restructuring effort. The company has confirmed that 67 jobs are targeted in Ghent and 32 at the head office in Diegem. This restructuring is necessary for Sanofi to modernize its organization and become a global player in immunology.
The company is focusing on developing new vaccines and drugs in immunology that can make a significant impact on patient care. Sanofi has twelve new medicines and vaccines in clinical development that show promise for treating immune-related diseases. As a result, some early-stage research activities in Ghent will be discontinued. Sanofi is exploring all possible solutions for employees affected by the job cuts.
On the other hand, solar battery technology plays a crucial role in storing energy generated by solar panels for later use. Similarly, photovoltaic cells convert sunlight into electricity, both of which contribute significantly to renewable energy sources and reducing carbon emissions. In 2024, the demand for these technologies is expected to continue growing as countries strive to meet their sustainability goals.
For more information on pharmaceutical developments, renewable energy technologies, and job restructuring efforts at Sanofi, please visit the company’s official website or contact their representatives directly.